#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12678	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2143	588.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1669	1669	T	702	T	638	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12678	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2143	588.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1403	1403	C	811	C	744	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22850	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3625	628.9	0	.	n	.	0	T695C	SNP	695	695	T	1027	1027	C	702	C,T	647,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22850	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3625	628.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1669	1669	A	785	A,G	726,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22850	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3625	628.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2303	2303	C	734	C,A,T	674,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22850	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3625	628.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2377	2377	A	690	A	643	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22850	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3625	628.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2929	2929	C	692	C	643	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	27	1800	folP	852	852	99.88	folP.l15.c17.ctg.1	1538	116.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4668	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3400	136.7	1	SNP	p	S91F	0	.	.	271	273	TCC	626	628	TCC	179;178;180	T;C;C	164;165;169	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4668	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3400	136.7	1	SNP	p	D95N	0	.	.	283	285	GAC	638	640	GAC	171;170;167	G;A;C	157;157;154	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4668	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3400	136.7	1	SNP	p	D95G	0	.	.	283	285	GAC	638	640	GAC	171;170;167	G;A;C	157;157;154	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1342	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1264	105.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	714	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	922	77.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1596	1598	GCA	186;185;184	G;C,T;A,G	168;163,1;162,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2079	2081	ATT	155;155;155	A;T;T	137;139;141	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	1	SNP	p	D86N	0	.	.	256	258	GAC	549	551	GAC	175;175;176	G;A;C	155;154;155	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	1	SNP	p	S87I	0	.	.	259	261	AGT	552	554	AGT	178;178;181	A;G;T	157;158;163	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	1	SNP	p	S87R	0	.	.	259	261	AGT	552	554	AGT	178;178;181	A;G;T	157;158;163	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	1	SNP	p	S87W	0	.	.	259	261	AGT	552	554	AGT	178;178;181	A;G;T	157;158;163	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4156	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2971	139.5	1	SNP	p	S88P	0	.	.	262	264	TCC	555	557	TCC	180;181;181	T;C;C	160;162;162	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3984	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2604	152.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1555	1557	GGC	201;199;198	G;G;C	189;187;185	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1227	1229	GCA	177;184;186	G;C;A	160;166;171	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1230	1232	ATC	187;191;188	A;T;C	171;176;170	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1242	1244	GTG	189;187;187	G;T,C;G,T	175;172,1;170,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1242	1244	GTG	189;187;187	G;T,C;G,T	175;172,1;170,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1746	1748	ACC	188;188;188	A;C;C	167;173;173	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1800	1802	GCG	163;163;166	G;C;G	145;132;141	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1800	1802	GCG	163;163;166	G;C;G	145;132;141	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1923	1925	GGT	149;150;151	G;G;T	129;130;130	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1932	1934	GGC	147;147;145	G;G;C	128;126;122	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	143.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1950	1952	CCG	135;136;139	C;C;G	98;118;109	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5004	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3166	157.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1608	1610	CTG	190;188;185	C;T;G	161;159;156	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1940	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1638	118.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	293	295	GGC	131;129;130	G;G;C	119;116;118	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1940	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1638	118.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	475	475	C	139	C	126	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	V75I	NONSYN	223	225	GTT	490	492	ATT	188;190;192	A;T;T	174;175;175	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	532	534	AGC	202;204;203	A;G;C	190;191;191	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	V98I	NONSYN	292	294	GTC	559	561	ATC	203;202;203	A;T;C	190;188;193	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	D121S	NONSYN	361	363	GAC	628	630	AGC	186;185;185	A;G;C,A	171;167;171,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	631	633	AAA	188;188;186	A;A;A	175;177;174	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	694	696	CAA	210;205;205	C;A;A	196;191;190	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	E212D	NONSYN	634	636	GAA	901	903	GAT	176;177;178	G,T;A;T	165,1;167;168	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	H213G	NONSYN	637	639	CAT	904	906	GGT	177;174;176	G;G;T	167;163;165	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	V215A	NONSYN	643	645	GTT	910	912	GCT	174;172;173	G;C;T	167;163;165	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	I218M	NONSYN	652	654	ATC	919	921	ATG	169;166;164	A;T;G	162;162;158	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	F222L	NONSYN	664	666	TTT	931	933	CTT	154;157;158	C,T;T;T	150,1;153;154	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1036	1038	ACG	153;152;153	A;C;G	143;144;145	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1042	1044	GTT	156;156;153	G;T;T	150;146;147	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1156	1158	AAC	193;192;189	A;A;C	171;170;171	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2340	porB1b	1047	1047	97.9	porB1b.l6.c4.ctg.1	1576	147.0	1	SNP	p	G120K	0	.	.	358	360	GGC	625	627	GGC	183;184;186	G;G;C	166;170;170	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9092	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4852	186.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2054	2056	CAT	178;179;182	C;A;T	168;168;171	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	926	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1143	80.9	1	SNP	p	V57M	0	.	.	169	171	GTG	524	526	GTG	203;203;204	G;T;G	188;186;190	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
